Qube Research & Technologies LTD Beyond Spring Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Beyond Spring Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 104 shares of BYSI stock, worth $244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104
Previous 2,604
96.01%
Holding current value
$244
Previous $9,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BYSI
# of Institutions
22Shares Held
5.77MCall Options Held
53.2KPut Options Held
2.5K-
Decheng Capital LLC Menlo Park, CA4.96MShares$11.7 Million3.65% of portfolio
-
Citigroup Inc454KShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$506,0840.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$69,2610.17% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$57,2640.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $91.5M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...